5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices

Brain Research

Volumn 757, Issue 1, 1997, Pages 17-23

  Ramirez M J ^a   Cenarruzabeitia, E ^a   Lasheras, B ^a   Del Rio, J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

5 HT2 rcceptor; Acetylcholine release; Dopamine receptor; Neurokinin; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; DOPAMINE 1 RECEPTOR; KETANSERIN; METHYSERGIDE; METITEPINE; NEUROKININ 1 RECEPTOR; ONDANSETRON; PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN]; QUINPIROLE; SEROTONIN 2A RECEPTOR; TETRODOTOXIN; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; ERGOLINE DERIVATIVE; HALOPERIDOL; MESULERGINE; PEPTIDE FRAGMENT; PHYSALAEMIN; POTASSIUM; RITANSERIN; SENKTIDE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUBSTANCE P;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC STIMULATION; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; PHYSIOLOGY; WISTAR RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ACETYLCHOLINE; ANIMALS; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ERGOLINES; HALOPERIDOL; KETANSERIN; MALE; PEPTIDE FRAGMENTS; PHYSALAEMIN; POTASSIUM; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, NEUROKININ-1; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN ANTAGONISTS; SUBSTANCE P;

EID: 0030611564     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01434-5     Document Type: Article

References (46)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-374.
2. 1 receptors. J. Pharmacol. Exp. Ther. 269:1994;1144-1151.
3. Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1994;1-28.
4. Arenas E., Alberch J., Perez-Navarro E, Solsona C., Marsal J. Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum. J. Neurosci. 11:1991;2332-2338.
5. 1 receptor expression by cholinergic interneurones in human striatum. NeuroReport. 5:1994;1597-1600.
6. 3H-choline from guinea-pig striatal slices. Br. J. Pharmacol. 86:1985;664P.
7. Benloucif B., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
8. 2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J. Neurochem. 54:1990;2145-2148.
9. 3H]acetylcholine release from guinea-pig striatal slices. Br. J. Pharmacol. 98:1989;213-221.
10. Bolam J., Ingham C.A., Izzo P.N., Pye D.B., Smith A.D., Wainer B.H. Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: A double immunocytochemical study in the rat. Brain Res. 397:1986;279-289.
11. Bolam J., Wainer B., Smith A.D. Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemestry. Golgi-impregnation and electron microscopy. Neuroscience. 12:1984;711-718.
12. Butcher S.H., Butcher L.L., Cho A.K. Modulation of neostriatal acetylcholine in the rat by dopamine and 5-hydroxytryptamine. Life Sci. 18:1976;733-744.
13. Damsma G., De Boer P., Westerink B.H., Fibiger H.C. Dopaminergic regulation of striatal cholinergic interneurons: An in vivo microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;523-527.
14. 1 and N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 259:1991;1064-1072.
15. De Boer P., Damsma G., Schram Q., Stoof J.C., Zaagsma J., Westerink B.H.C. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;144-148.
16. Drapeau G., D'Orleans-Juste P., Dion S., Rhaleb N.E., Regoli D. Selective agonists for substance P and neurokinin receptors. Neuropeptides. 10:1987;43.
17. Ferre S., Cortes R., Artigas F. Dopaminergic regulation of the serotonergic raphe-striatal pathway: Microdialysis studies in freely moving rats. J. Neurosci. 14:1994;4839-4846.
18. 2 receptors throughout the rat central nervous system using quantitative autoradiography. Brain Res. 421:1987;263-279.
19. 2+ mobilization and release of acetylcholine from guinea-pig neostriatal slices. Br. J. Pharmacol. 91:1987;287-297.
20. 2 dopamine receptor regulated gene expression of striatonigral and striato-pallidal neurons. Science. 250:1990;1429-1432.
21. Gerfen C.R. Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the rat striatum and basal forebrain. Brain Res. 556:1991;165.
22. Gillet G., Ammor S., Fillion G. Serotonin inhibits acetylcholine release from rat striatum slices. Evidence for a presynaptic receptor-mediated effect. J. Neurochem. 45:1985;1687-1691.
23. Graybiel A.M., Baughman R.W., Eckenstein F. Cholinergic neuropil of the striatum observes striosomal boundaries. Nature. 323:1986;625-628.
24. S. Guard and S.P. Watson, Tachykinin receptor types: Classification and membrane signalling mechanisms. Neurochem. Int., (1991) 149-165.
25. 1 and DARPP-32 gene expression in the rat striatum: An in situ hibridization study. Mol. Brain Res. 12:1992;131-139.
26. Jackson D., Stachowiak M.K., Bruno J.P., Zigmond M.J. Inhibition of striatal acetylcholine release by endogenous serotonin. Brain Res. 457:1988;259-266.
27. Johnson B.P., Bruno J.P. Dopaminergic modulation of striatal acetylcholine release in rats depleted of dopamine as neonates. Neuropharmacology. 34:1995;191-203.
28. Leysen J.E., Gommeren W., Eens A., De Chaffoy De Courcelles D., Stoof J.C., Janssen P.A. Biochemical profile of risperidone, a new antipsychotic. J. Pharmacol. Exp. Ther. 247:1988;661-670.
29. Leysen J.E., Gommmeren W., Van Gompel P., Wynants J., Jamssen P.F.M., Laduron P.M. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin S2 antagonist. Mol. Pharmacol. 27:1985;600-611.
30. Leysen J.E., Gommeren W., Laduron P.M. Spiperone: A ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. Biochem. Pharmacol. 27:1978;307-316.
31. Mantyh P.W., Gates T., Mantyh C.R., Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 9:1989;258-279.
32. Marien M.R., Richard J.W. Drug effects on the release of endogenous acetylcholine in vivo: Measurement by intracerebral dialysis and gas chromatography-mass spectrometry. J. Neurochem. 54:1990;2016-2020.
33. Miller J.J., Richardson T.L., Fibiger H.C., McLennan H. Anatomical and electrophysiological identification of a projection from mesencephalic raphe to the caudate-putamen of the rat. Brain Res. 97:1975;133-138.
34. 2 receptor immunoreactivity on cholinergic neurons of the pontomesencephalic tegmentum shown by double immunofluorescence. Brain Res. 627:1993;49-54.
35. 1 receptors. Eur. J. Pharmacol. 192:1991;203-204.
36. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: An electrophysiological study in vivo. J. Pharmacol. Exp. Ther. 271:1994;83-90.
37. Ramirez M.J., Del Rio J., Cenarruzabeitia E., Lasheras B. On the nature of the 5-HT receptor subtype inhibiting acetylcholine release in the guinea-pig ileum. Br. J. Pharmacol. 113:1994;77-80.
38. 3 receptor blockade in slices from rat entorhinal cortex. Brain Res. 712:1996;274-280.
39. Steinberg R., Rodier D., Souilhac J., Bougault I., Edmonds-Alt X., Soubrie P., Le Fur G. Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: An in vivo microdialysis study. J. Neurochem. 65:1995;2543-2548.
40. Stoof J.C., Drukarch B., De Boer P., Westerink B.H.C., Groenewegen H.J. Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience. 47:1992;755-770.
41. Van Der Kooy D., Kuypers H.G.J.M. Fluorescent retrograde double labeling: Axonal branching in the ascending raphe and nigral projections. Science. 204:1979;873-875.
42. Vizi E.S., Harsing L.G., Zsilla G. Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurons. Brain Res. 212:1981;89-99.
43. Walker P., Ni L., Riley L., Jonakait G., Hart R. Serotonin innervation affects SP biosynthesis in rat neostriatum. Ann. NY Acad. Sci. 632:1991;485-487.
44. Wilson C.J., Chang H.T., Kitai S.T. Firing patterns and synaptic potentials of identified giant aspiny interneurons in the neostriatum. J. Neurosci. 10:1990;508-519.
45. Wormser U., Laufer R., Hart Y., Chorev M., Gilon C., Selinger Z. Highly selective agonist for substance P receptor subtypes. EMBO J. 5:1986;2805-2808.
46. +-evoked dopamine release from rat olfatory tubercle and striatal slices. Br. J. Pharmacol. 113:1994;968-972.